# Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

> **NCT02556411** · NA · UNKNOWN · sponsor: **University of Cagliari** · enrollment: 50 (estimated)

## Conditions studied

- Adenomyosis
- Chronic Pelvic Pain

## Interventions

- **DRUG:** LNG-IUS 13,5 mg Levonorgestrel
- **DRUG:** Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg

## Key facts

- **NCT ID:** NCT02556411
- **Lead sponsor:** University of Cagliari
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02556411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02556411, "Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02556411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*